S2 E91 - Transforming Cancer Treatment: Nicole Paulk’s Bold Mission with Siren Biotechnology
Biotech Pioneer Nicole Paulk Aims to Revolutionize Cancer Care with Innovative Gene Therapy and Crowdfunding
Nicole Paulk’s Siren Biotechnology transforms viruses into targeted cancer therapies with universal potential. The company focuses on recurrent high-grade gliomas, a fatal brain cancer with no standard treatment. Nicole left academia to lead Siren, leveraging her groundbreaking virology research to launch the company. Siren’s unique crowdfunding campaign lets patients and families invest in the fight against cancer. Nicole’s superpower, fearless innovation, drives her bold mission to revolutionize cancer care.
#CancerTreatment #GeneTherapy #BiotechInnovation #CancerResearch #CrowdfundingForGood #BrainCancerAwareness #MedicalBreakthrough #CancerCare #ImpactInvesting #SirenBiotechnology